1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc XNAS: IBRX
2.14 0.04 (1.90%)
5.4M
XNAS Volume

XNAS 24 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

ImmunityBio Inc - IBRX - stock price prediction, stock price target, analyst ratings from 5 analysts

ImmunityBio Inc has a share price target of US$ 10, revenue growth forecast of 652.3%, and profit growth estimate of 6.5% for FY25, based on top 5 analyst calls.